APA (7th ed.) Citation

Singh, A. K., Phatak, S. R., Singh, R., Bhattacharjee, K., Singh, N. K., Gupta, A., & Sharma, A. (2021). Antibody response after first and second-dose of ChAdOx1-nCOV (CovishieldTM®) and BBV-152 (CovaxinTM®) among health care workers in India: The final results of cross-sectional coronavirus vaccine-induced antibody titre (COVAT) study. Vaccine, 39(44), 6492-6509. https://doi.org/10.1016/j.vaccine.2021.09.055

Chicago Style (17th ed.) Citation

Singh, Awadhesh Kumar, Sanjeev Ratnakar Phatak, Ritu Singh, Kingshuk Bhattacharjee, Nagendra Kumar Singh, Arvind Gupta, and Arvind Sharma. "Antibody Response After First and Second-dose of ChAdOx1-nCOV (CovishieldTM®) and BBV-152 (CovaxinTM®) Among Health Care Workers in India: The Final Results of Cross-sectional Coronavirus Vaccine-induced Antibody Titre (COVAT) Study." Vaccine 39, no. 44 (2021): 6492-6509. https://doi.org/10.1016/j.vaccine.2021.09.055.

MLA (9th ed.) Citation

Singh, Awadhesh Kumar, et al. "Antibody Response After First and Second-dose of ChAdOx1-nCOV (CovishieldTM®) and BBV-152 (CovaxinTM®) Among Health Care Workers in India: The Final Results of Cross-sectional Coronavirus Vaccine-induced Antibody Titre (COVAT) Study." Vaccine, vol. 39, no. 44, 2021, pp. 6492-6509, https://doi.org/10.1016/j.vaccine.2021.09.055.